Application of Incident Command Structure to clinical trial management in the academic setting: principles and lessons learned

Penny S Reynolds, Mary J Michael, Bruce D Spiess, Penny S Reynolds, Mary J Michael, Bruce D Spiess

Abstract

Background: Clinical trial success depends on appropriate management, but practical guidance to trial organisation and planning is lacking. The Incident Command System (ICS) is the 'gold standard' management system developed for managing diverse operations in major incident and public health arenas. It enables effective and flexible management through integration of personnel, procedures, resources, and communications within a common hierarchical organisational structure. Conventional ICS organisation consists of five function modules: Command, Planning, Operations, Logistics, and Finance/Administration. Large clinical trials will require a separate Regulatory Administrative arm, and an Information arm, consisting of dedicated data management and information technology staff. We applied ICS principles to organisation and management of the Prehospital Use of Plasma in Traumatic Haemorrhage (PUPTH) trial. This trial was a multidepartmental, multiagency, randomised clinical trial investigating prehospital administration of thawed plasma on mortality and coagulation response in severely injured trauma patients. We describe the ICS system as it would apply to large clinical trials in general, and the benefits, barriers, and lessons learned in utilising ICS principles to reorganise and coordinate the PUPTH trial.

Results: Without a formal trial management structure, early stages of the trial were characterised by inertia and organisational confusion. Implementing ICS improved organisation, coordination, and communication between multiple agencies and service groups, and greatly streamlined regulatory compliance administration. However, unfamiliarity of clinicians with ICS culture, conflicting resource allocation priorities, and communication bottlenecks were significant barriers.

Conclusions: ICS is a flexible and powerful organisational tool for managing large complex clinical trials. However, for successful implementation the cultural, psychological, and social environment of trial participants must be accounted for, and personnel need to be educated in the basics of ICS.

Trial registration: ClinicalTrials.gov, NCT02303964 . Registered on 28 November 2014.

Keywords: ICS; Incident Command Structure; Trial failure; Trial management.

Figures

Fig. 1
Fig. 1
Conventional clinical trial management architecture (adapted from [9]). This is ‘flat land’ management [10], as the lead investigator is directly involved with all aspects of trial management. Although communication chains are short, the lead investigator can be easily overwhelmed by information and low-level decision-making
Fig. 2
Fig. 2
Incident Command Structure as applied to clinical trial management. Advantages are more manageable span of control, more effective coordination of diverse tasks, and more effective allocation of tasks and functions to teams with specific expertise and oversight skills
Fig. 3
Fig. 3
Generalised task flow maps for the PUPTH trial. Integration of Patient Flow with Information Flow maps was crucial for identifying barriers to data collection; blood samples (non-standard information) had to be collected at predesignated time points; however, patient location in the hospital care chain at those times could not be predicted in advance
Fig. 4
Fig. 4
Incident Command Structure as applied to management of the PUPTH trial. This schematic clearly identified chains of command, responsible personnel, and task and service units. It made for more effective allocation and monitoring of tasks, simplified coordination and coverage of essential service personnel, and improved accountability

References

    1. Retzios AD. Why do so many phase 3 clinical trials fail? Part 1: the effect of deficient phase 2 trials in therapeutic areas with high failure rates in phase 3 studies. Bay Clinical R&D Services; 2010. p. 46. .
    1. Waring M J, Arrowsmith J, Leach AR, Leeson PD, Mandrell S, Owen RM, Pairaudeau G, Pennie WD, Pickett SD, Wang J, Wallace O, Wei A. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nature Reviews Drug Discovery. Published online 19 June 2015; doi:10.1038/nrd4609
    1. Buonansegna E, Salomo S, Maier AM, Li-Ying J. Pharmaceutical new product development: why do clinical trials fail? R&D Manag. 2014;44(2):189–202. doi: 10.1111/radm.12053.
    1. Smyth RMD, Jacoby A, Altman DG, Gamble C, Williamson PR. The natural history of conducting and reporting clinical trials: interviews with trialists. Trials. 2015;16:16. doi: 10.1186/s13063-014-0536-6.
    1. Calleam Consulting Ltd. Why do projects fail? (blog). International Project Leadership Academy. .
    1. Farrell B, Kenyon S, on behalf of the UK Trial Managers’ Network: a guide to efficient trial management. 4th ed. 2014
    1. Farrell B, Kenyon S, Shakur H. Managing clinical trials. Trials. 2010;11:78. doi: 10.1186/1745-6215-11-78.
    1. European Medicines Agency. Guideline For Good Clinical Practice E6(R2). EMA/CHMP/ICH/135/1995. 2016. p. 75.
    1. Sprague S, Bhandari M. Chap 6. Organization and planning. p 161-185, In: Clinical trials handbook, edited by Shayne Cox Gad. New York: Wiley; 2009. p. 944.
    1. Cannon J, Cannon J. Leadership lessons of the Navy Seals. New York: McGraw-Hill Education; 2005. p. 240.
    1. Baer AR, Devine S, Beardmore CD, Catalano R. Attributes of exemplary research: clinical investigator responsibilities. J Oncol Pract. 2011;7(2):124–7. doi: 10.1200/JOP.2010.000216.
    1. English R, Lebovitz Y, Griffin R. Transforming clinical research in the United States: challenges and opportunities. Forum on Drug Discovery, Development, and Translation; Institute of Medicine. Washington, D.C: National Academies Press; 2010. p. 150. doi:10.17226/12900.
    1. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999;52(12):1143–56. doi: 10.1016/S0895-4356(99)00141-9.
    1. Academy of Clinical Research Professionals. Clinical Research Coordinator Detailed Content Outline. 2012. Retrieved from .
    1. Reynolds PS, Michael MJ, Cochran ED, Wegelin JA, Spiess BD. Prehospital use of plasma in traumatic haemorrhage (The PUPTH Trial): study protocol for a randomised controlled trial. Trials. 2015;16:321. doi: 10.1186/s13063-015-0844-5.
    1. Federal Emergency Management Agency (FEMA). Introduction to Incident Command System, ICS-100 [Training Program]. Federal Emergency Management Agency. .
    1. Ang-Olson J, Latoski S. Simplified guide to the Incident Command System for transportation professionals. Technical Report FWHA-HOP-06-004. Washington DC: US Department of Transportation Federal Highway Administration Office of Operations; p. 64. .
    1. Barbera JA, Macintyre AG. Medical surge capacity and capability: a management system for integrating medical and health resources during large-scale emergencies. 2nd ed. U.S.: Department of Health and Human Services; 2007. .
    1. Genik L, Smith DG. Command and control analysis of the Southwest Provincial Regional Emergency Operations Centre during Vancouver 2010. 2011. .
    1. Adams EH, Scanlon E, Callahan JJ, Carney MT. Utilization of an Incident Command System for a public health threat: West Nile Virus in Nassau County, New York, 2008. J Public Health Manag Pract. 2010;16(4):309–15. doi: 10.1097/PHH.0b013e3181bb8392.
    1. U.S. Department of Homeland Security. National Response Framework. January 2008. Retrieved from .
    1. Wiesman J, Melnick A, Bright J, Carreon C, Richards K, Sherrill J, Vines J. Lessons learned from a policy decision to coordinate a multi-jurisdiction H1N1 response with a single incident management team. J Public Health Manag Pract. 2011;17(1):28–35. doi: 10.1097/PHH.0b013e3181fd4cd2.
    1. Bigley GA, Roberts KH. The Incident Command System: high-reliability organizing for complex and volatile task environments. Acad Manag J. 2001;44(6):1281–99. doi: 10.2307/3069401.
    1. Federal Emergency Management Agency (FEMA). NIMS and the Incident Command System. 2004. .
    1. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry: E6 (R2) Good Clinical Practice: Consolidated Guidance. 1996. p. 63.
    1. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for industry: investigator responsibilities—protecting the rights, safety, and welfare of study subjects. 2009. p. 15.
    1. DeAngelis CD, Fontanarosa PB. Ensuring integrity in industry-sponsored research: Primum non nocere, revisited. JAMA. 2010;303(12):1196–8. doi: 10.1001/jama.2010.337.
    1. Wilhelmsen L. Role of the Data and Safety Monitoring Committee (DSMC) Stat Med. 2002;21:2823–9. doi: 10.1002/sim.1286.
    1. DAMOCLES Study Group A proposed charter for clinical trial data monitoring committees: helping them to do their job well. Lancet. 2005;365:711–22. doi: 10.1016/S0140-6736(05)70939-9.
    1. Robinson ET, Baron D, Heise LL, Moffatt J, Harlan SV. Communications handbook for clinical trials: strategies, tips, and tools to manage controversy, convey your message, and disseminate results. Triangle Park: Family Health International, Research Triangle Park; 2011. p. 281.
    1. Champion KM, Jones GR. Chap 16. Planning an academic clinical trial. In: Wolfgang Walther and Ulrike Stein, editors. Gene therapy of solid cancers: methods and protocols, methods in molecular biology, vol. 1317. New York: Springer Science + Business Media; 2015. doi:10.1007/978-1-4939-2727-2_16.
    1. Jones CT, Jester PM, FitzGerald M. Issues in research management: protocol challenges in the era of complexity. Res Pract. 2011;12(4):1–11.
    1. Woodin KE. The CRC’s guide to coordinating clinical research. 2. Boston: CenterWatch; 2011. p. 611.
    1. Bhardwaj SS, Camacho F, Derrow A, Fleischer AB, Jr, Feldman SR. Statistical significance and clinical relevance: the importance of power in clinical trials in dermatology. JAMA Dermatol. 2004;140(12):1520–3. doi: 10.1001/archderm.140.12.1520.
    1. Dilts DM, Sandler AB. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol. 2006;24:4545–52. doi: 10.1200/JCO.2005.05.0104.
    1. Gygi C, Williams B, DeCarlo N. Six Sigma for dummies®. 2. Hoboken: Wiley; 2012. Mapping to identify possible factors. Ch 7.
    1. NHS Institute for Innovation and Improvement . Improvement leaders’ guides: process mapping, analysis and redesign. Coventry: NHS Institute; 2005.
    1. Kaitin KI, editor. Protocol design optimization starting to improve study performance. Tufts Center for the Study of Drug Development Impact Report. 2014;16(5). .
    1. Kohavi R, Henne RH, Sommerfield D. Practical guide to controlled experiments on the Web: listen to your customers not to the HiPPO. Knowledge Discovery and Data Mining (KDD). 2007. .
    1. Freeman S, Williams HC, Dellavalle RP. The increasing importance of systematic reviews in clinical dermatology research and publication. J Investig Dermatol. 2006;126:2357–60. doi: 10.1038/sj.jid.5700560.
    1. Ioannidis JPA. Perfect study, poor evidence: interpretation of biases preceding study design. Semin Hematol. 2008;45:160–6. doi: 10.1053/j.seminhematol.2008.04.010.
    1. Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, Howells DH, Ioannidis JPA, Oliver S. Research: Increasing value, reducing waste 1: how to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156–65. doi: 10.1016/S0140-6736(13)62229-1.
    1. FEMA. Handbook for EMS medical directors. Washington DC: United States Fire Administration FA-197; 2012. p. 92.
    1. Stup, R. Standard Operating Procedures: a writing guide. College of Agricultural Sciences Agricultural Research and Cooperative Extension, Pennsylvania State University; 2001. p. 8. .
    1. Center for Clinical Research and Technology Clinical Research SOP Committee University Hospitals, Case Medical Center. Development and maintenance of Standard Operating Procedures (SOPs) 3/2012 SOP No: GA-101, p. 5. .
    1. FEMA. Developing effective Standard Operating Procedures for Fire and EMS departments. Washington DC: United States Fire Administration FA-197; 1999. p. 102. .
    1. Greenberg G. Logistics and management of clinical trials. Br J Clin Pharmacol. 1982;14:25–30. doi: 10.1111/j.1365-2125.1982.tb04930.x.

Source: PubMed

3
購読する